LATISSE® was approved by the U.S. Food and Drug Administration (FDA) in 2008. It is a treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE® is the first and only FDA-approved, science-based treatment to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.
LATISSE® is a once-daily prescription treatment applied to the base of the upper eyelashes. To do so you use a sterile, single-use-per-eye disposable applicator. Individuals who use LATISSE® can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain the effect, continued treatment with LATISSE® is required. Discontinuation of treatment will result in the eyelashes gradually returning to where they were prior to treatment over a period of weeks to months.